MoneyWorks4Me

Medicamen Biotech - Quaterly Results

11 Nov 2022 Evaluate
A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 335.32 millions against Rs. 325.20 millions during year ago period.A slender decline of -14.47% was recorded to Rs. 36.11  millions from Rs. 42.22 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 63.80 millions from 67.03 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 335.32 325.20 3.11 666.20 600.50 10.94 1154.45 1101.46 4.81
Other Income 5.25 4.76 10.29 14.87 5.55 167.93 17.20 7.54 128.12
PBIDT 63.80 67.03 -4.82 129.99 128.22 1.38 252.74 203.35 24.29
Interest 6.16 3.00 105.33 13.83 3.44 302.03 14.01 10.64 31.67
PBDT 57.64 64.03 -9.98 116.16 124.78 -6.91 238.73 192.71 23.88
Depreciation 16.15 13.50 19.63 31.42 26.80 17.24 57.71 25.20 129.01
PBT 41.49 50.53 -17.89 84.74 97.98 -13.51 181.02 167.51 8.07
TAX 5.38 8.31 -35.26 12.77 14.25 -10.39 31.97 42.65 -25.04
Deferred Tax -3.24 -3.99 -18.80 -5.63 -4.65 21.08 -7.80 1.19 -755.46
PAT 36.11 42.22 -14.47 71.97 83.73 -14.05 149.05 124.86 19.37
Equity 126.51 122.17 3.55 126.51 122.17 3.55 122.17 122.17 0.00
PBIDTM(%) 19.03 20.61 -7.69 19.51 21.35 -8.62 21.89 18.46 18.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..